Repository logo
 

Investigating platelet and endothelial activation in ART-treated women living with HIV and obesity.

dc.contributor.advisorNkambule, Bongani Brian.
dc.contributor.advisorHanley, Sherika.
dc.contributor.authorMfusi, Snenhlanhla Angel.
dc.date.accessioned2023-08-02T09:51:34Z
dc.date.available2023-08-02T09:51:34Z
dc.date.created2022
dc.date.issued2022
dc.descriptionMasters Degree. University of KwaZulu-Natal, Durban.en_US
dc.description.abstractBackground: Antiretroviral therapy (ART) has reduced morbidity and mortality in people living with Human immunodeficiency virus (PLWH). However, metabolic and thrombotic complications have now become prevalent in the aging population of PLWH. The spectrum of cardiovascular disease in patients with HIV is broad and the mechanisms underlying the risk of cardiovascular disease (CVD) in PLWH remains complex and multifactorial. This includes an interplay between traditional risk factors such as obesity which in the general population is more prevalent in women. This study aimed to assess the association between platelet activation, endothelial activation and CVD-risk in women living with HIV. Methods: In this study we included 66 female participants living with HIV (n=33 normal weight and n=33 overweight/obese) enrolled in the prospective multi-country PEPFAR PROMise Ongoing Treatment Evaluation (PROMOTE) study from the Umlazi clinical research site. The time of blood draws ranges from December 2018- November 2019. We measured the levels of high sensitivity creactive protein (hsCRP), lipid profiles, platelet activation (P-selectin, CD36 and platelet factor-4) and markers of endothelial activation (endothelin-1, von Willebrand factor). Results:Women living with HIV(WLHIV) and obesity showed significantly elevated levels of soluble CD36 4.36[2.71-9.53] when compared to the control group 2.79[2.24-3.55], p=0.0064. Furthermore, the levels of (vWF) were elevated in WLHIV and obesity 8.83[1.59-9.78] when compared to controls 5.34[0.65-7.7] p=0.0009. However, the levels of soluble P-selectin, platelet factor-4 (PF4) and endothelin-1 (ET-1) were comparable between two study groups (p>0.05). Lastly, the levels of hsCRP levels were significantly higher in WLHIV and obesity (7.71±9.95) when compared to controls (3.68±5.89) p= 0.0005. Conclusion: The levels of platelet and endothelial activation are elevated in WLHIV and obesity despite successful ART. Moreover, the levels of inflammation remain persistently high even during ART. Therefore, WLHIV and obesity are at an increased risk of developing CVD.en_US
dc.identifier.urihttps://researchspace.ukzn.ac.za/handle/10413/22074
dc.language.isoenen_US
dc.subject.otherCardiovascular disease.en_US
dc.subject.otherObesity.en_US
dc.subject.otherAntiretroviral therapy.en_US
dc.subject.otherPlatelet activation.en_US
dc.subject.otherEndothelial activation.en_US
dc.titleInvestigating platelet and endothelial activation in ART-treated women living with HIV and obesity.en_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mfusi_Snenhlanhla _Angel_2022.pdf
Size:
4.57 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.64 KB
Format:
Item-specific license agreed upon to submission
Description: